Ruofei Zhu

No ORCID on file · 6 papers in corpus · active 2019-2024

Study types

  • article 3
  • review 2
  • other 1

Condition tags

  • endometriosis 6
  • endometrioma 1
article 2024
Current medicinal chemistry ·doi:10.2174/0109298673283426231220100011

AIMS: To explore the diagnostic biomarkers for diagnosing endometriosis. BACKGROUND: Endometriosis is a benign, progressive, estrogen-dependent gynecological disorder that has highly variant prevalence. Therefore, it is essential to develo…

other 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-021-00604-4

It is suggested that aberrantly expressed microRNAs are involved in the pathogenesis of endometriosis. Our previous study demonstrated that expression of the microRNA hsa-miR-199a-3p is attenuated in human endometriotic cyst stromal cells (…

review 2021
Medical molecular morphology ·doi:10.1007/s00795-021-00308-3

Endometriosis is a benign tumor that affect 6-10% women of reproductive age. To date, it is suggested that the aberrant microRNA (miRNA) expressions play important roles in the pathogenesis of endometriosis. Reviewing the literature, we fou…

review 2021
Medical molecular morphology ·doi:10.1007/s00795-021-00303-8

Endometriosis is a common, estrogen-dependent benign tumor that affect 3-10% women of reproductive age, and is characterized by the ectopic growth of endometrial tissue, which is found primarily in the rectovaginal septum, ovaries, and pelv…

article 2020
Journal of reproductive immunology ·doi:10.1016/j.jri.2020.103100

Endometriosis is a chronic inflammatory disease which is associated with aberrant chemokine expression. We have established a three-dimensional (3D) floating collagen gel culture of human endometriotic cyst stromal cells (ECSCs) as an in vi…

article 2019
Molecular human reproduction ·doi:10.1093/molehr/gaz016

A number of genes involved in the pathogenesis of endometriosis are silenced by the hypermethylation of their promoter regions. We assessed the effect and mechanism of the DNA demethylating agent 5-aza-2'-deoxycytidine (5-aza-dC) (10 μM) on…